✦ LIBER ✦

Phase I study of mitozolomide on a once daily for 5 days schedule

✍ Scribed by Jan H. Schornagel; Godelaine Simonetti; Ria Dubbelman; Wim W. ten Bokkel Huinink; J. Gordon McVie

Publisher: Springer
Year: 1990
Tongue: English
Weight: 173 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02897208

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of oral menogaril administ

Phase I study of oral menogaril administered on a once weekly schedule

✍ David J. Stewart; Shailendra Verma; Jean A. Maroun; Lucille Robillard; Robert H. 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 741 KB

Forty-seven patients with solid tumors were treated on a phase I study of menogaril administered by mouth once per week. Nausea and vomiting were excessive at weekly doses of 350 and 450 mg/m2/week but were tolerable and controlled reasonably well by antiemetics at lower doses. There appeared to be

A phase I study of etoposide phosphate a

A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days*

✍ Thompson, Dana S.; Greco, F. Anthony; Miller, Antonius A.; Srinivas, Nuggehally 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 860 KB

Pharmacokinetic study of temozolomide on

Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas: first study in Asians

✍ Tomokazu Aoki; Ryo Nishikawa; Tomohiko Mizutani; Kuniharu Nojima; Kazuhiko Mishi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 382 KB

A Phase I clinical trial of ixabepilone

A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days

✍ Sen H. Zhuang; Manish Agrawal; Maureen Edgerly; Susan Bakke; Herb Kotz; Paul Tha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND The epothilones are a novel class of microtubule‐stabilizing agents. Ixabepilone (BMS‐247550; NSC 710428) is a semisynthetic analog of the natural product epothilone B. The authors conducted a Phase I study by administering ixabepilone to patients as a 1‐hour intravenous

Phase-I study of a new schedule based on

Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisation

✍ Jean-Pierre Delord; Frédéric Léger; Pierre Canal; Muriel Poublanc; Roland Bugat; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 234 KB

Phase I trial of Adozelesin using the tr

Phase I trial of Adozelesin using the treatment schedule of daily × 5 every 3 weeks

✍ Brenda J. Foster; Patricia M. LoRusso; Elizabeth Poplin; Mark Zalupski; Manuel V 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 525 KB